NCT04211363 - Trial of PDE4 Inhibition With Roflumilast for the Management of Plaque Psoriasis | Biotech Hunter

Enrollment

439

Participants

Timeline

Start Date

December 20, 2019

Primary Completion Date

November 16, 2020

Study Completion Date

November 16, 2020

Conditions

Chronic Plaque Psoriasis

Interventions

DRUG

Roflumilast 0.3% cream

Roflumilast 0.3% cream for topical application.

DRUG

Vehicle Cream

Vehicle cream for topical application.

Trial Locations (40)

10029

Arcutis Biotherapeutics Clinical Site 121, New York

11790

Arcutis Biotherapeutics Clinical Site 108, Stony Brook

14623

Arcutis Biotherapeutics Clinical Site 130, Rochester

15213

Arcutis Biotherapeutics Clinical Site 135, Pittsburgh

16635

Arcutis Biotherapeutics Clinical Site 128, Duncansville

19003

Arcutis Biotherapeutics Clinical Site 113, Exton

20850

Arcutis Biotherapeutics Clinical Site 125, Rockville

Arcutis Biotherapeutics Clinical Site 138, Rockville

27262

Arcutis Biotherapeutics Clinical Site 115, High Point

32771

Arcutis Biotherapeutics Clinical Site 105, Sanford

33174

Arcutis Biotherapeutics Clinical Site 131, Miami

33484

Arcutis Biotherapeutics Clinical Site 118, Delray Beach

34470

Arcutis Biotherapeutics Clinical Site 137, Ocala

45324

Arcutis Biotherapeutics Clinical Site 124, Fairborn

46168

Arcutis Biotherapeutics Clinical Site 114, Plainfield

48038

Arcutis Biotherapeutics Clinical Site 116, Clinton Township

60008

Arcutis Biotherapeutics Clinical Site 102, Rolling Meadows

70809

Arcutis Biotherapeutics Clinical Site 111, Baton Rouge

73118

Arcutis Biotherapeutics Clinical Site 134, Oklahoma City

75246

Arcutis Biotherapeutics Clinical Site 119, Dallas

77845

Arcutis Biotherapeutics Clinical Site 104, College Station

78218

Arcutis Biotherapeutics Clinical Site 110, San Antonio

78229

Arcutis Biotherapeutics Clinical Site 117, San Antonio

89509

Arcutis Biotherapeutics Clinical Site 139, Reno

92024

Arcutis Biotherapeutics Clinical Site 127, Encinitas

92123

Arcutis Biotherapeutics Clinical Site 123, San Diego

92697

Arcutis Biotherapeutics Clinical Site 120, Irvine

94132

Arcutis Biotherapeutics Clinical Site 136, San Francisco

94538

Arcutis Biotherapeutics Clinical Site 112, Fremont

02135

Arcutis Biotherapeutics Clinical Site 101, Brighton

08520

Arcutis Biotherapeutics Clinical Site 129, East Windsor

T1Y 0B4

Arcutis Biotherapeutics Clinical Site 132, Calgary

N6H 5L5

Arcutis Biotherapeutics Clinical Site 103, London

L3P 1X2

Arcutis Biotherapeutics Clinical Site 122, Markham

L5H 1G9

Arcutis Biotherapeutics Clinical Site 133, Mississauga

K2C 3N2

Arcutis Biotherapeutics Clinical Site 140, Ottawa

K9J 5K2

Arcutis Biotherapeutics Clinical Site 109, Peterborough

N2J 1C4

Arcutis Biotherapeutics Clinical Site 106, Waterloo

H3Z 2S6

Arcutis Biotherapeutics Clinical Site 107, Montreal

G1V4X7

Arcutis Biotherapeutics Clinical Site 126, Québec